I presume you’re asking about the 2003 NVS-MNTA agreement, which is the one that governs Lovenox commercialization in the US. The agreement, with dollar amounts and dates redacted, is at http://sec.gov/Archives/edgar/data/1235010/000104746904007521/a2130432zex-10_4.txt . Note: a separate NVS-MNTA agreement inked in 2006 governs the Copaxone program in all jurisdictions and the Lovenox program in the EU.